Vyluma has announced that the National Medical Products Administration (NMPA) of China has accepted ...

AI Optics, a medical device company specializing in artificial intelligence-driven ophthalmic soluti...

The European Medicines Agency (EMA) has issued its third Letter of Support to the Macustar consortiu...

Harrow, a leading eye care pharmaceutical company in North America, has announced the launch of Harr...

SeaBeLife has announced promising in vivo preclinical results for its investigational drug SBL03, an...

Viralgen and Axovia Therapeutics have announced a strategic collaboration to develop and manufacture...

Apellis Pharmaceuticals has announced that the Therapeutic Goods Administration (TGA) of Australia h...

Norlase, a global leader in ophthalmic laser technology, has announced the commercial launch of LYNX...

MERIT, a global provider of clinical trial endpoint and technology services, has announced the acqui...

Outlook Therapeutics shared results from the NORSE EIGHT clinical trial at the Hawaiian Eye and Reti...